Presented by
Matthias Klaften

Nominated by

Karlsruhe Institute of Technology

 

Cancer is one of the major causes of death worldwide with an expected 13.3 million deaths in 2020. While modern target-specific drugs and medical technology offer an improved treatment of the primary tumor, the effective treatment of metastases as the main cause of death from cancer is still in its beginning. As one of the very few companies, amcure develops a novel approach with a proven effect on the primary tumor, the tumor spreading (metastasis), as well the remission of already established metastases. By addressing the novel target CD44v6, a co-receptor for several critical cellular pathways for cancer development and metastasis, amcure combines the advantages of a target specific and a broadband drug therapy. If the effect observed in several relevant animal models can be proven in clinical studies, the company has the potential to offer a breakthrough therapy giving new hope for patients with metastasizing carcinomas that cannot yet be treated adequately.

More Venture Finalists

All Venture Finalists

Further Activities to have a look at

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Privacy Preference Center

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Necessary Cookies

These cookies are required to provide you with our site and its functions. Since storing these cookies is necessary for the provision of our site and its functions, you cannot disable them. If you block these cookies via you browser settings our site may not function properly.

Analyse Cookies

These cookies enable us to use website analytics in order to improve our site or provide you with personalized content. They may be set by us or by third party providers whose services we have added to our pages.

Marketing Cookies

These cookies enable us to use online marketing and advertising in order to provide you on this or on other sites with personalized advertisement. They may be set by us or by third party providers whose services we have added to our pages.